HCV-IN-33
HCV-IN-33 (Compound (S) -3i) is an HCV entry inhibitor[1].
Product Specifications
CAS Number
[2757963-83-8]
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-in-33.html
Solubility
10 mM in DMSO
Smiles
N#CC(C=CC(N1CCN(CCC1)C)=C2)=C2CN(CC3)CCN3[C@@H](C4=CC=CC=C4)C5=CC=C(C=C5)Cl
Molecular Formula
C31H36ClN5
Molecular Weight
514.10
References & Citations
[1]Wang Y, et al. Design, Synthesis, and Biological Evaluation of 2- ((4-Bisarylmethyl-piperazin-1-yl) methyl) benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65 (3) :2107-2121.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
129561-ML750 100 µL
MEF2D (Myocyte-specific Enhancer Factor 2D, DKFZp686I1536) (MaxLight 750) discontinued
Ask
View Details